Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT00975767 |
Title | A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung Cancer |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | MethylGene Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Barbara Ann Karmanos Cancer Center | Detroit | Michigan | 48201 | United States | Details | |
Duke University Medical Center | Durham | North Carolina | 27710 | United States | Details | |
University of Pennsylvania Abramson Cancer Center | Philadelphia | Pennsylvania | 19104 | United States | Details | |
The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
South Texas Accelerated Research Therapeutics, LLC | San Antonio | Texas | 78229 | United States | Details |